Role of cytochrome P-450 in reperfusion injury of the rabbit lung.

Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc Natl Acad Sci U S A (2004) 2.11

Apocynin: molecular aptitudes. Mediators Inflamm (2008) 1.77

Therapeutic antioxidant medical gas. J Clin Biochem Nutr (2008) 1.29

Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol (2015) 1.19

Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J (1993) 1.18

Cytochrome P-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci U S A (1994) 1.10

Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo. Am J Physiol Lung Cell Mol Physiol (2013) 1.01

Cimetidine does not prevent lung injury in newborn premature infants. Pediatr Res (2006) 0.91

Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat. Br J Pharmacol (2002) 0.89

Carbon monoxide-saturated preservation solution protects lung grafts from ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2008) 0.86

Relationship between peroxisome proliferator-activated receptors (PPAR alpha and PPAR gamma) and endothelium-dependent relaxation in streptozotocin-induced diabetic rats. Br J Pharmacol (2003) 0.85

Cytochrome-P450 2B1 gene silencing attenuates puromycin aminonucleoside-induced cytotoxicity in glomerular epithelial cells. Kidney Int (2010) 0.79

Cytochrome P450 2B1 mediates complement-dependent sublytic injury in a model of membranous nephropathy. J Biol Chem (2010) 0.75

Microsomal lipid peroxidation. Methods Enzymol (1978) 16.78

Hydroperoxide metabolism in mammalian organs. Physiol Rev (1979) 14.13

Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J (1984) 13.20

Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med (1985) 11.68

Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch Biochem Biophys (1986) 4.67

Oxygen activation by cytochrome P-450. Annu Rev Biochem (1980) 3.44

Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J Biol Chem (1984) 2.86

The requirement for iron (III) in the initiation of lipid peroxidation by iron (II) and hydrogen peroxide. J Biol Chem (1987) 2.12

Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS Lett (1986) 1.97

Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. Circulation (1987) 1.64

Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem (1985) 1.51

Hyperoxia increases H2O2 release by lung mitochondria and microsomes. Arch Biochem Biophys (1982) 1.51

The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J Biol Chem (1986) 1.43

A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radic Biol Med (1988) 1.41

Evidence for superoxide generation by NADPH-cytochrome c reductase of rat liver microsomes. Biochem Biophys Res Commun (1972) 1.32

The mechanism of NADPH-dependent lipid peroxidation. The propagation of lipid peroxidation. J Biol Chem (1979) 1.30

Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterology (1982) 1.27

Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450. Drug Metab Dispos (1983) 1.22

A quantitative test for superoxide radicals produced in biological systems. Biochem J (1982) 1.22

Hemoglobin-mediated oxidant damage to the central nervous system requires endogenous ascorbate. J Clin Invest (1988) 1.15

Release of iron from ferritin by xanthine oxidase. Role of the superoxide radical. Biochem J (1987) 1.10

Free radical-producing enzyme, xanthine oxidase, is undetectable in human hearts. Am J Physiol (1987) 1.04

Spectrophotometric study of several sensitive reagents for serum iron. Clin Biochem (1981) 1.02

Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest (1989) 1.01

Generation of superoxide anion as a source of hydrogen peroxide in a reconstituted monooxygenase system. FEBS Lett (1978) 0.98

Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol (1987) 0.94

Metabolic sources of reactive oxygen metabolites during oxidant stress and ischemia with reperfusion. Clin Chest Med (1989) 0.91

Pulmonary edema after pulmonary artery occlusion and reperfusion. Am Rev Respir Dis (1989) 0.89

Cytochrome P-450 and oxygen toxicity. Oxygen-dependent induction of ethanol-inducible cytochrome P-450 (IIE1) in rat liver and lung. Biochemistry (1989) 0.89

Influence of flavin addition and removal on the formation of superoxide by NADPH-Cytochrome P-450 reductase: a spin-trap study. Arch Biochem Biophys (1981) 0.89

Reoxygenation injury in isolated hepatocytes: cell death precedes conversion of xanthine dehydrogenase to xanthine oxidase. Biochem Biophys Res Commun (1988) 0.88

Myocardial tissue iron delocalization and evidence for lipid peroxidation after two hours of ischemia. Ann Emerg Med (1986) 0.86

Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrest. J Free Radic Biol Med (1985) 0.86

Cytochrome P450-linked p-nitroanisole O-demethylation in the perfused lung. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.84

Activation of 8-methoxypsoralen by cytochrome P-450. Enzyme kinetics of covalent binding and influence of inhibitors and inducers of drug metabolism. Biochem Pharmacol (1989) 0.80

Pyridine nucleotide redox state and blood flow of the cerebral cortex following middle cerebral artery occlusion in the cat. Stroke (1976) 0.80

Hepatic glutathione and hepatotoxicity: effects of cytochrome P-450 complexing compounds SKF 525-A, L-alpha acetylmethadol (LAAM), norLAAM, and piperonyl butoxide. Biochem Pharmacol (1982) 0.80

Arrhythmias and infarction in the ischemic pig heart are not mediated by xanthine oxidase-derived free oxygen radicals. Basic Res Cardiol (1988) 0.79

Lack of inhibition of mouse catalase activity by cimetidine: an argument against a relevant general effect of cimetidine upon heme metabolic pathways. Biochem Pharmacol (1987) 0.79

Effect of hypoxia and CO on a cytochrome P-450-mediated reaction in rabbit lungs. J Appl Physiol Respir Environ Exerc Physiol (1981) 0.78

Inactivation of cytochrome P-450 by the drug methoxsalen. J Pharmacol Exp Ther (1986) 0.78

Relationship between alveolar PO2 and the rate of p-nitroanisole O-demethylation by the cytochrome P-450 pathway in isolated rabbit lungs. J Clin Invest (1979) 0.77

The role of metal ions in ischemia/reperfusion injury in skin flaps. J Surg Res (1989) 0.77

Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest (1984) 2.88

Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J Clin Invest (1988) 2.54

Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest (1979) 2.40

Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci U S A (1982) 1.99

Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97

Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J Biol Chem (1991) 1.96

Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood (1990) 1.71

Altered oxidative metabolic responses in vitro of alveolar macrophages from asymptomatic cigarette smokers. Am Rev Respir Dis (1981) 1.64

Alveolar hemorrhage syndromes: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) (1984) 1.62

Cloning, genomic organization, chromosomal assignment and expression of a novel mosaic serine proteinase: epitheliasin. FEBS Lett (2000) 1.57

Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J Infect Dis (1982) 1.47

Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J Infect Dis (1981) 1.46

Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest (1987) 1.43

Dusts causing pneumoconiosis generate .OH and produce hemolysis by acting as Fenton catalysts. Arch Biochem Biophys (1989) 1.41

Alterations in leukocyte oxidative metabolism in cigarette smokers. Am Rev Respir Dis (1982) 1.36

Phagocytosis by polymorphonuclear leukocytes of Staphylococcus aureus and Pseudomonas aeruginosa adherent to plastic, agar, or glass. J Immunol Methods (1983) 1.36

Role of surface complexed iron in oxidant generation and lung inflammation induced by silicates. Am J Physiol (1992) 1.36

Human dipeptidyl-peptidase I. Gene characterization, localization, and expression. J Biol Chem (1997) 1.35

Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis (1983) 1.35

Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis (1981) 1.33

Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells. Am J Physiol (1998) 1.31

Copper-dependent inflammation and nuclear factor-kappaB activation by particulate air pollution. Am J Respir Cell Mol Biol (1998) 1.30

Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest (1992) 1.25

Pathogenesis of emphysema. Chest (1983) 1.22

Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet (1982) 1.20

Lung phagocyte recruitment and metabolic alterations induced by cigarette smoke in humans and in hamsters. Am Rev Respir Dis (1982) 1.19

Lung fibrosis and emphysema: divergent responses to a common injury? Science (1982) 1.18

Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation. J Immunol (1994) 1.17

Influence of subinhibitory concentrations of penicillin, cephalothin, and clindamycin on Staphylococcus aureus growth in human phagocytic cells. Antimicrob Agents Chemother (1982) 1.14

Influence of cationic local anesthetics on the metabolism and ultrastructure of human alveolar macrophages. J Lab Clin Med (1979) 1.12

Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am J Respir Crit Care Med (1995) 1.11

TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am J Physiol (1999) 1.10

Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am J Respir Cell Mol Biol (1990) 1.10

Radiation therapy for tracheobronchial amyloidosis. Chest (1998) 1.10

Disruption of protein tyrosine phosphate homeostasis in bronchial epithelial cells exposed to oil fly ash. Am J Physiol (1997) 1.08

Phagocytosis by human alveolar macrophages and neutrophils: qualitative differences in the opsonic requirements for uptake of Staphylococcus aureus and Streptococcus pneumoniae in vitro. Am Rev Respir Dis (1980) 1.07

Nifedipine inhibits hypoxic pulmonary vasoconstriction during rest and exercise in patients with chronic obstructive pulmonary disease. A controlled double-blind study. Am Rev Respir Dis (1984) 1.06

Requirement for reactive oxygen species in serum-induced and platelet-derived growth factor-induced growth of airway smooth muscle. J Biol Chem (1999) 1.06

Amyloid infiltration of the diaphragm as a cause of respiratory failure. Chest (1986) 1.05

Endothelial activation in ARDS. Chest (1999) 1.04

Production of C2 by human alveolar macrophages. Immunology (1978) 1.04

Opsonin-independent phagocytosis of surface-adherent bacteria by human alveolar macrophages. J Leukoc Biol (1984) 1.04

Cellularity of the alveolar walls in smokers and its relation to alveolar destruction. Functional implications. Am Rev Respir Dis (1990) 1.03

Chemiluminescence by human alveolar macrophages: stimulation with heat-killed bacteria or phorobol myristate acetate. Infect Immun (1977) 1.03

Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). Genomics (1996) 1.02

Role of reactive oxygen species in reperfusion injury of the rabbit lung. J Clin Invest (1989) 1.01

Nonanticoagulant heparin inhibits NF-kappaB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol (2000) 1.01

Expression and regulation of tumor necrosis factor in macrophages from cystic fibrosis patients. Am J Respir Cell Mol Biol (1993) 1.01

Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. Am J Physiol (1996) 1.00

DNA strand breaks following in vitro exposure to asbestos increase with surface-complexed [Fe3+]. Arch Biochem Biophys (1994) 1.00

Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones. J Med Chem (1999) 0.99

Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase. Am Rev Respir Dis (1985) 0.98

Partial reaction of prolyl hydroxylase. (Gly-PRO-Ala)n stimulates alpha-ketoglutarate decarboxylation without prolyl hydroxylation. J Biol Chem (1978) 0.98

Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells. Am J Physiol Cell Physiol (2001) 0.97

Collagen structure in solution. I. Kinetics of helix regeneration in single-chain gelatins. Biochemistry (1970) 0.97

Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest (1993) 0.97

Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene. J Appl Physiol (1985) (1989) 0.97

Production of hydroxyl radical by human alveolar macrophages. Infect Immun (1979) 0.97

Differences in phagocytosis and killing by alveolar macrophages from humans, rabbits, rats, and hamsters. Infect Immun (1982) 0.96

Molecular cloning, tissue expression of human xanthine dehydrogenase. Biochem Biophys Res Commun (1994) 0.96

Cloning and characterization of the cDNA and gene for human epitheliasin. Eur J Biochem (2001) 0.95

Regulation of Ca(2+)-activated K+ channels in pulmonary vascular smooth muscle cells: role of nitric oxide. J Appl Physiol (1985) (1996) 0.94

Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G. J Biol Chem (1996) 0.94

Reversible impairment of the adherence of alveolar macrophages from cigarette smokers. Am Rev Respir Dis (1978) 0.94

Gadolinium chloride inhibits pulmonary macrophage influx and prevents O(2)-induced pulmonary hypertension in the neonatal rat. Pediatr Res (2001) 0.93

Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci. J Clin Invest (1982) 0.92

Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen. J Biol Chem (1992) 0.92

Impairment of human alveolar macrophage oxygen consumption, and superoxide anion production by local anesthetics used in bronchoscopy. Chest (1979) 0.92

Lung T cells in hypersensitivity pneumonitis. Ann Intern Med (1984) 0.92

Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am J Respir Cell Mol Biol (1993) 0.92

Repressed expression of the human xanthine oxidoreductase gene. E-box and TATA-like elements restrict ground state transcriptional activity. J Biol Chem (2000) 0.91

Production of opsonins that facilitate phagocytosis of Streptococcus pneumoniae by human alveolar macrophages or neutrophils after vaccination with pneumococcal polysaccharide. Am Rev Respir Dis (1981) 0.91

Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element. J Biol Chem (1996) 0.91

Opsonization of Legionella pneumophila in human serum: key roles for specific antibodies and the classical complement pathway. Immunology (1985) 0.91

Pulmonary function and respiratory symptoms in polyvinylchloride fabrication workers. Am Rev Respir Dis (1985) 0.90

Reduction of neutrophil influx diminishes lung injury and mortality following phosgene inhalation. J Appl Physiol (1985) (1991) 0.90

Defective oxidative metabolic responses in vitro of alveolar macrophages in chronic granulomatous disease. Am Rev Respir Dis (1979) 0.89

Bronchiolitis and rheumatoid arthritis. Am Rev Respir Dis (1981) 0.89

Role of a novel KCa opener in regulating K+ channels of hypoxic human pulmonary vascular cells. Am J Respir Cell Mol Biol (1999) 0.89

Comparison of the metabolism of alveolar macrophages from humans, rats, and rabbits: phorbol myristate acetate. J Lab Clin Med (1978) 0.89

Cigarette smoking causes accumulation of polymorphonuclear leukocytes in alveolar septum. Am Rev Respir Dis (1985) 0.88

Alterations in the course of acid-induced lung injury in rats after general anesthesia: volatile anesthetics versus ketamine. Anesth Analg (1998) 0.88

Nitric oxide donor prevents hydrogen peroxide-mediated endothelial cell injury. Am J Physiol (1996) 0.88

Hypothesis: is lung disease after silicate inhalation caused by oxidant generation? Lancet (1990) 0.88

Genetics of COPD: present and future. Eur Respir J (2001) 0.87

Human neutrophil proteinase 3: mapping of the substrate binding site using peptidyl thiobenzyl esters. Biochem Biophys Res Commun (1992) 0.87

Dehydroepiandrosterone and analogs inhibit DNA binding of AP-1 and airway smooth muscle proliferation. J Pharmacol Exp Ther (1998) 0.87

Induction of urokinase-type plasminogen activator receptor by IL-1 beta. Am J Respir Cell Mol Biol (1997) 0.86